Internal Medicine Alert – October 15, 2013
October 15, 2013
View Issues
-
Pharmacology Watch: Evidence-based updates in clinical pharmacology
Medications for Risk Reduction of Breast Cancer in Women -
Is it ‘Low T’ or ‘Low E’ or Both?
In men 20-50 years of age, testosterone deficiency accounted for decreases in lean muscle mass, size, and strength while estrogen deficiency primarily accounted for increases in body fat, and both contributed to the decline in sexual function. -
Hyperglycemia, Insulin Resistance, and the Risk of Pancreatic Cancer
There is a known association of obesity and glucose intolerance with pancreatic cancer but whether this is due to the effect of high glucose itself, insulin resistance, or pancreatic ß-cell dysfunction is unknown. -
Brief Reports
-
Pharmacology Update: Afatinib Tablets (Gilotrif)
An irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) has been approved for first-line treatment of non-small cell lung cancer (NSCLC) with certain EGFR mutations. -
Clinical Briefs By Louis Kuritzky
-
ECG Review: The Cause of T Wave Inversion?